Navigation Links
Colubris Demonstrates Wide-Ranging Mobility Solutions for Healthcare
Date:2/25/2008

Participation in HIMSS Highlights Myriad Opportunities for Using Wireless

to Improve Efficiency and Accuracy of Patient Care

WALTHAM, Mass., Feb. 25 /PRNewswire/ -- Colubris Networks, the leading global provider of intelligent wireless LANs (WLANs) for enterprises and service providers, will leverage its participation in the 2008 Annual HIMSS Conference & Exhibition, taking place February 24-28 in Orlando, FL, to showcase how the company's wireless technologies, including those supporting the 802.11n standard, can be used to significantly improve patient care in today's hospitals, clinics and medical centers.

In addition to highlighting the award-winning Colubris Intelligent Mobility Solution, a powerful WLAN system for the healthcare industry, the company will also demonstrate how its Wireless Client Bridge 200 (WCB-200) is being used to wirelessly enable a variety of legacy medical equipment. With the Colubris WCB-200, hospitals have the ability to cost-effectively give wireless capabilities to non-wireless medical devices, such as cardiac monitors, mobile X-ray equipment, pulse oximetry equipment and high-definition video carts -- without the added expense of replacing equipment.

Colubris Networks delivers the most secure, wireless networking solution tailored to meet the stringent, real-time needs of healthcare providers. Colubris dramatically boosts hospital staff productivity and response time by providing caregivers with anywhere, anytime voice communications and bedside access to key clinical support applications and electronic medical records (EMR) -- ultimately enhancing the quality of care delivered to patients. Further, Colubris safeguards the integrity of confidential patient information as it travels over the wireless network, allowing organizations to fully comply with the Health Insurance Portability and Accountability Act (HIPAA) regulations for patient privacy. Unlike other vendor offerings, Colubris' state-o
'/>"/>

SOURCE Colubris Networks
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Palmer College of Chiropractic Selects Colubris Networks to Provide Wireless Infrastructure at Three U.S. Campuses
2. Cardiac Science Corporation Selects Colubris Networks Wireless Solution for its Portable Electrocardiograph
3. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
4. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
5. Highmarks Hospital Pay-for-Performance Program Demonstrates Impressive Results
6. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
7. LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon
8. ENDEAVOR IV achieves primary endpoint, demonstrates similar safety profile compared to Taxus stent
9. New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer
10. Data Show SuperGens Multi-Targeted Tyrosine Kinase Inhibitor Demonstrates Pre-clinical Activity in Glioblastoma Multiforme
11. First in the World Live Case Using New Technology Demonstrates Shorter Procedure Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3
..., April 24 Prime Therapeutics (Prime), a,thought ...oday that,Rachelle Wan, RPh, has joined the organi...ns., As Vice President of Pharmacy Trade Relation...rategic pharmacy,contracts and the performance of ...
...April 24 Life Brokerage Partners,announces three ...ms with,Peach Holdings, Inc. ("Peachtree"), Polari...premium finance programs are particularly valuable... and UNF,do not end with the agents, but extend to...
... Reveals Americans Are in Overdrive, Trend Exper...s Expert Denise Austin Offers Nightl...fter a long day at the,office, do you reach for yo...er than ever before, often at the expense of,their...
..., N.J., April 24 Cambrex,Corporation (NYSE: CBM ...8,financial results on Thursday, May 1, 2008 after...i-bin/prnh/20000613/CAMBREXLOGO ), The Company w... Thursday, May 1, 2008 at 5:00 p.m. Easter...
...homa Society and Ralph Lauren Center for Cancer Ca...Be Certified, NEW YORK, April 24 The Harold P. F...d that representatives from the Leukemia,& Lymphom...nic were the first to be trained in patient naviga...
...l 23 Young Innovations, Inc.,(Nasdaq: YDNT ) tod...1,2008., Sales for the first quarter of 2008 were...% from the $22.9 million reported in the first qua...come,was essentially unchanged at $2.8 million, co...
Other Medicine News:Health News:Life Brokerage Partners Strengthens Premium Finance Programs 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 3Health News:Wired, Working Americans Let Nighttime Health Routines Slide 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 2Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 3Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 5Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 6Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 2Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 3Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 4Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 5
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6William Dwyer Named to PerfectServe Advisory Board 57496 1William Dwyer Named to PerfectServe Advisory Board 57496 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...-Funded Immune Globulin Study Uncovers Sample,Mani...PRNewswire-USNewswire/ -- An analysis,released tod...,study ruling out a link between autism and Rh imm...ained the mercury-based,preservative thimerosal. B...red manipulation of the study sample, so that,earl...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3
QuikCoag CaCl2
QuikCoag Control 2
..., compact design. Using optical light scatter for ...YN 3200 meets the needs of today's laboratory. The...-part differential analysis, automated sample hand...y. The system combines proven Multi-Angle Polarize...
Perclose A-T Suture-Mediated Closure
Medicine Products: